---
id: FC-003
type: Flashcard
created: 2025-08-08 09:58:27.903478
tags:
- Flashcard
- question
- infectious
topic: infectious
answer: D
related_articles:
- title: 'Resistant Bacterial Infections: Guidelines From the Infectious Diseases
    Society of America.'
  path: 2024/2024-08-resistant-bacterial-infections-guidelines-from-the-infectiou.md
  similarity: 0.833
  link: '[[2024/2024-08-resistant-bacterial-infections-guidelines-from-the-infectiou|Resistant
    Bacterial Infections: Guidelines From the Infectious Diseases Society of America.]]'
- title: ACG Guideline for Treatment of Helicobacter pylori Infection in Adults.
  path: 2025/2025-03-acg-guideline-for-treatment-of-helicobacter-pylori-infection.md
  similarity: 0.8
  link: '[[2025/2025-03-acg-guideline-for-treatment-of-helicobacter-pylori-infection|ACG
    Guideline for Treatment of Helicobacter pylori Infection in Adults.]]'
- title: Considerations for Implementing Cabotegravir (Apretude) as PrEP for HIV Infection.
  path: 2024/2024-04-considerations-for-implementing-cabotegravir-apretude-as-pre.md
  similarity: 0.8
  link: '[[2024/2024-04-considerations-for-implementing-cabotegravir-apretude-as-pre|Considerations
    for Implementing Cabotegravir (Apretude) as PrEP for HIV Infection.]]'
- title: Preexposure Prophylaxis to Prevent Acquisition of HIV.
  path: 2023/2023-12-preexposure-prophylaxis-to-prevent-acquisition-of-hiv.md
  similarity: 0.8
  link: '[[2023/2023-12-preexposure-prophylaxis-to-prevent-acquisition-of-hiv|Preexposure
    Prophylaxis to Prevent Acquisition of HIV.]]'
- title: Doxycycline Preferred for the Treatment of Chlamydia.
  path: 2022/2022-11-doxycycline-preferred-for-the-treatment-of-chlamydia.md
  similarity: 0.8
  link: '[[2022/2022-11-doxycycline-preferred-for-the-treatment-of-chlamydia|Doxycycline
    Preferred for the Treatment of Chlamydia.]]'
topics:
- Emergency Medicine
- Infectious Disease
---

# Flashcard FC-003

## Question

Yourpatientreportssymptomssuggestiveof SARS-Co V-2 infection. which one of the following statementsaboutpoint-of-carerapidantigentestingis correct? Ithashighersensitivityinpatientswhoaresymptomaticvs.asymptomatic. Ithashighersensitivityduringthefirstweekofillnesscomparedwithlaterinthediseasecourse. Itismorespecificthansensitive. Alloftheabove. @ Back

## Answer

**D**

## Explanation

Theaveragesensitivityandspecificityofrapidantigentestingfor SARS-Co V-2 were69.3(95 Cl, 66.2 to72.3)and99.3(95 Cl,99.2 to99.3),respectively. Averagesensitivitywasgreaterin thosewhohadsymptoms(73.0;95 Cl,.69.3 to76.4)vs.thosewithoutsymptoms(54.7;95 Cl,47.7 to61.6). Sensitivitywashigherinpatientswhohadsymptomsforoneweekorless(80.9; 95 Cl,76.9 to84.4)comparedwiththoseintheirsecondweekofsymptoms(53.8;95 Cl, 48.0 to59.6). e

## References

- AAFPQuestion Bank-Pythonsimplecapture.
- whoaresymptomaticvs.
- whohadsymptoms(73.
- whohadsymptomsforoneweekorless(80.

